Concepedia

Eugenie S. Kleinerman

ES

Statistics

Publications

161

Citations

9.5K

H-Index

54

Active since

1974

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

National Institutes of Health

Baylor College of Medicine

Eugenie S. Kleinerman is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and metastasis.

ORCID

Publications per year

1974–2024

161

Publications

161

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 748 citations · Full text

, , +14

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 719 citations · Full text

, , +15

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

Alexander J. Chou, Eugenie S. Kleinerman, Mark Krailo et al. · Cancer · 2009 · 239 citations · Full text

, , +14

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

Chand Khanna, Timothy M. Fan, Richard Görlick et al. · Clinical Cancer Research · 2014 · 199 citations · Full text

, , +13

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

Richard Görlick, Peter M. Anderson, Irene L. Andrulis et al. · PubMed · 2003 · 198 citations

, , +16

1–5 of 161